Providing Customers the Best in Big Data Technologies, High-Performance Analytics and Healthcare Information Capabilities DANBURY, CT, and REDWOOD SHORES, CA, June 14, 2016 – IMS Health (NYSE:IMS), ...

Pursuing claims-based data on what happens to patients taking their drugs, pharma companies have been striking pacts with payers and PBMs. Now, a heavyweight in the research field, IMS Health, has ...

On Jan. 11, 2012, AstraZeneca and IMS Health announced a three-year collaboration to use real-world healthcare data from Europe to inform AstraZeneca's discovery and clinical development programs. On ...

Dutch publishing and market research company, VNU, is to buy healthcare data provider, IMS Health, in a €5.8 billion-euro ($7 billion-dollar) cash and share deal. Dutch publishing and market research ...

There are striking parallels between Cinderella’s situation and the most deprived patients with hepatitis C in England. Data from IMS Health highlights the increasing inequality, in terms of ...

There are more than twice as many health apps as there were in 2013, but whether those apps are better tools for doctors and patients is a mixed bag: while apps today are more likely than two years ...

As the global market for pharmaceuticals surpasses $1 trillion this year, a new study has identified 10 “harbingers of disruptive change” which, it says, represent turning points in the role of ...

In July, the Commission took the unusual step of granting NDC a compulsory licence before completing its probe into whether IMS Health was abusing its dominant position. Both NDC and Belgian rival ...

Explore Ims Health stock price history with detailed daily historical prices, including open, high, low, and volume data. Review stock chart history to analyze past trends and find the highest Ims ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. IMS Health, a provider of prescription-drug data, agreed to sell itself to TPG Capital and Canada Pension ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. IMS Health, a provider of prescription-drug data, agreed to sell itself to TPG Capital and Canada Pension ...